ReviewJournal of lipid research2025
Multiple facets of HDLs as modifiable risk factors in stroke-the good, the bad, and the ugly.
Review in Journal of lipid research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Age-related metabolomic signatures and stroke susceptibility in a population-based cohort.GeroScience · 2026Article
- Elevated NHHR at admission is independently associated with elevated post-stroke depressive symptoms.Frontiers in psychiatry · 2026Article
- Prognostic value of admission NHHR for functional recovery in acute ischemic stroke.Frontiers in endocrinology · 2026Article
- Is Crocin Effective in Modulating Blood Lipid Levels? An Updated Systematic Review and Meta-Analysis with Dose- and Time-Response Assessments.Pharmaceuticals (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HDL as a component of the lipid profile has been extensively studied for its link to CVDs, particularly its relationship with atherogenesis. It has been observed that plasma levels of HDL-C display an inverse relationship with stroke as well, suggesting that higher levels could potentially reduce the risk of stroke. Nevertheless, recent studies suggest that HDL-C alone may not fully predict stroke risk. The complexity of HDL particles arises from their diverse nature, showing significant heterogeneity in various dimensions. The functional quality of HDL extends beyond its quantity, with factors like lipoprotein subspecies (varying in size, lipid compositions, microRNA, and protein content) influencing HDL functionality under different pathophysiological conditions. This heterogeneity of HDL, particularly in the context of stroke, has received limited attention in reviews. While some studies have suggested that higher levels of HDL-C are linked to a reduced risk of stroke, others have found no such association. While HDL is known for its atheroprotective effects, its antioxidant and anti-inflammatory properties may be as vital as cholesterol efflux in preventing atherosclerosis-related stroke. This review emphasizes the importance of exploring various functionalities of HDL in the context of stroke.By elucidating the multifaceted relationship between HDL and stroke as demonstrated by contemporary literature, we aim to enhance the understanding of HDL's influence on stroke pathophysiology and identify avenues for future research in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.